SCHEMBL24664731

SCHEMBL24664731

CCCN1CCN(C(=O)OCC(F)(F)F)CC1=O

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 8/20 0.51
▸ ALDH1A1 P00352 4/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ PARP2 Q9UGN5 1/20 0.35
▸ KCNH2 Q12809 2/20 0.33
▸ GPR119 Q8TDV5 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ P2RY12 Q9H244 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27369454 0.89 P2RX7 (0.49) P2RX7ALDH1A1MEN1KMT2AHPGD
SCHEMBL24664424 0.83 P2RX7 (0.52) P2RX7HPGDSMN1; SMN2PARP1PARP2
SCHEMBL1583254 0.80 P2RX7 (0.41) P2RX7MEN1KMT2AHPGDPARP1
SCHEMBL1583253 0.79 P2RX7 (0.46) P2RX7ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL16475199 0.75 TMEM97 (0.52) P2RX7MEN1KMT2ASMN1; SMN2
SCHEMBL7868166 0.75 LMNA (0.46) P2RX7ALDH1A1SMN1; SMN2MAPTPARP1
SCHEMBL13472124 0.74 P2RX7 (0.48) P2RX7MEN1KMT2APARP1PARP2
SCHEMBL17624340 0.73 CYP1A2 (0.42) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL18824250 0.72 LMNA (0.46) P2RX7ALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL1583540 0.71 CNR2 (0.40) P2RX7ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059665-A1 DIMERIC COMPOUNDS AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-03-21 — — WO disclosed
WO-2022198196-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2022-09-22 — — WO disclosed
Send feedback